Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Fibroblast Transplantation for Facial Deformities
NCT01115634Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Sep 2008
- Primary completion
- Sep 2015
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azficel-t in craniofacial anomalies (CFA) and acne scars, sponsored by Royan Institute. Primary endpoint: 2-point shift in at least one treated area using a standardized 7-point photoguide at 6 months. Started Sep 2008; status: completed.
02
Drugs
azficel-t
03
Conditions
craniofacial anomalies (CFA)acne scars
Beyond the preview
Go deeper on NCT01115634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01115634.